Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
87.8
General Information
Revision date
2019-06-20
Product name
Ketorolac Tromethamine Injection, USP
Product name
Ketorolac Tromethamine Injection, USP
Identification on the label/Trade name
Ketorolac Tromethamine Injection
Chemical name
±-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxyli acid,Compound with 2-amino-2-(hydroxymethyl)-1,3- propanediol (1:1)
1.2.1 Relevant identified uses
Pharmaceutical, injectable
Manufacturer Name
Gland pharma Limited
Emergency telephone
+91-40-30510999
Icons in SDS
Company Information
company name
Gland pharma Limited
Section 2
SECTION 2: Hazards identification
OSHA Primary Physical and Health Hazards In the workplace, ketorolac tromethamine should be considered a potent drug, and possibly irritating to the eyes. Possible target organs include the gastrointestinal system, hematopoietic system, central nervous system, cardiovascular system, kidneys, liver, and possibly the eyes. Ketorolac affects the central nervous system and has relatively low acute toxicity. Chronic toxicity will result only on excessive repetitive exposure. Chronic Toxicity effects may be seen at the digestive system.
Principle Routes of Exposure
Signs & Symptoms of Exposure Skin and eye absorption, ingestion, inhalation Common adverse effects to excessive exposure include nausea, vomiting, gastrointestinal irritation, diarrhea, fatigue, insomnia, headache and dizziness. Chemical Listed as Carcinogen
Medical Conditions Generally Aggravated by Exposure
– Allergies to non-steroidal, anti-inflammatory drugs such as aspirin. Page | 1 SECTION 3 – COMPOSITION AND INGRIDIENTS 3.1. Drug Substances No data found 3.2. Drug mixture Name Product Identifier % Ketorolac Tromethamine 74103-07-4 1.5 64-17-5 10.0 Ethanol 7647-14-5 0.7 Sodium Chloride 7732-18-5 87.8 Water for Injection
